• March is  Myeloma Awareness Month
  • ASH 2014 Meeting Highlights
  • Earn CME Now
  • FAQ's

    FAQ Library

    Respected thought leaders answer frequently asked questions on issues important to your practice – available in video, audio, and transcript formats.

  • FAQ's

    Meeting Highlights

    Video and written highlights from major annual meetings regarding the most current multiple myeloma clinical study findings–one of our most popular features!

  • FAQ's

    CE Activities

    Accredited activities that focus on the assessment, diagnosis and treatment of multiple myeloma. Each activity highlights clinically relevant, timely and accurate scientific information, designed to support you in your search for additional education and improved patient care.

What's New

FAQ Library
Dr. Edward A. Stadtmauer answers new FAQs
Expert Perspectives
Expert Perspective in Multiple Myeloma: An Update on the New International Myeloma Working Group (IMWG) Guidelines
George Davatelis, PhD with Sagar Lonial, MD
Journal Club Library
Four recent abstracts with associated “Impact on Practice” are provided.
CE Activity
How Do I Treat the Newly Diagnosed Frail Patient Presenting with Infection, Peripheral Neuropathy, and Hyperglycemia?
Joseph D. Tariman, PhD, ANP-BC
CE Activity
Factors Affecting Treatment Adherence and Managing Treatment-associated Side Effects to Improve Adherence
Marie Sabo Recine, MS, and Eugene R. Tombler, PhD – Contributing authors
CE Activity
How Do I Treat the Newly Diagnosed Frail Patient Presenting with Infection, Peripheral Neuropathy and Hyperglycemia? Managing the Side Effects of Therapy
Beth Faiman, PhDc, RN, MSN, APRN-BC, AOCN©
CE Activity
Promising Emerging Therapies in Multiple Myeloma Poised to Make an Impact on Clinical Practice
Marie Sabo Recine, MS, and Eugene R. Tombler, PhD – Contributing authors
CE Activity
Duration of Therapy for Newly Diagnosed Multiple Myeloma Patients
Robert Z. Orlowski, MD, PhD; Houry Leblebjian, PharmD, BCOP; Joseph D. Tariman, PhD
CE Activity
How Should New Agents Be Incorporated Into Treatment?
Kenneth C. Anderson, MD – Moderator, R. Donald Harvey III, PharmD, FCCP, BCOP, and Sandra E. Kurtin, RN, MS, AOCN®, ANP-C